List of news
-
Featured news story
Published on: 10 January 2025
Researchers at UCLH, the Francis Crick Institute, and the UCL Cancer Institute have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used clinical risk factors.
-
Category: UCLH news
Published on: 22 January 2025
Digital accessibility and sustainability drive a switch to online patient information at UCLH
-
Category: Research news
Published on: 20 January 2025
Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen around twenty years before a clinical motor diagnosis in people with Huntington’s disease, a new study at UCLH and UCL has found.
-
Category: UCLH news
Published on: 20 January 2025
Last year, UCLH Arts & Heritage and our resident doctor community worked collaboratively to run a series of 10 creative workshops looking at various art-making methods aimed at improving the wellbeing of doctors.
-
Category: Research news
Published on: 16 January 2025
A new study at UCLH and UCL aims to extend survival for some patients with cancer in the biliary tract by treating them with therapies specifically tailored to the genetic profile of their tumour.
-
Category: Research news
Published on: 15 January 2025
Members of the public can now join a registry of healthy volunteers willing to be contacted about taking part in health research.
-
Category: Charity news
Published on: 08 January 2025
We would like to say a huge thank you to everyone who supported the end of year Gift of Giving appeal in December.
-
Category: UCLH news
Published on: 08 January 2025
Next generation testing, artificial intelligence, advanced mass spectrometry and machine learning is about to be used for diagnostics in the U.K. thanks to a new partnership between UCLH and Guilford Street Laboratories (GSL).
-
Category: UCLH news
Published on: 06 January 2025
UCLH is pleased to announce two new Board appointments for 2025.
-
Category: Research news
Published on: 23 December 2024
A UCLH patient has received an innovative treatment for radiotherapy-induced dry mouth, an irreversible serious adverse effect of head and neck cancer radiotherapy that causes permanent impairment of talking and eating.
-
Category: UCLH news
Published on: 20 December 2024
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
